| Literature DB >> 30684274 |
Atena Soleimani1, Majid Khazaei2,3, Gordon A Ferns4, Mikhail Ryzhikov5, Amir Avan2,6, Seyed Mahdi Hassanian1,2.
Abstract
Transforming growth factor β (TGF-β) modulates tumor progression by regulating cell proliferation, apoptosis, metastasis, angiogenesis, and drug resistance. Biological and pharmacological agonists/antagonists, the interplay between intracellular signaling pathways, and microRNAs (miRNAs) control the initiation and activation of the TGF-β signaling pathway. It has been proposed that the expression profiles of tumor suppressor and oncogenic TGF-β miRNAs may be used for the classification, diagnosis, and prognosis of human malignancies. Deregulated miRNAs and aberrant activation of TGF-β signaling are frequently found in human colorectal cancers (CRCs), but a little is known about their mechanisms of action in the development and progression of colorectal carcinoma. This review summarizes the current knowledge of the role of TGF-β signaling regulatory miRNAs in the pathogenesis of CRC for a better understanding and hence better management of this disease.Entities:
Keywords: TGF-β signaling; colorectal cancer; microRNA
Year: 2019 PMID: 30684274 DOI: 10.1002/jcp.28169
Source DB: PubMed Journal: J Cell Physiol ISSN: 0021-9541 Impact factor: 6.384